Cargando…
Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma
Immunodeficiencies are widely becoming known as important features of multiple myeloma (MM) and may promote the proliferation of malignant cells as well as confer resistance to therapy. Few studies focus on the immunomodulatory effects of the complement system on MM. This study aims to explore the r...
Autores principales: | Xu, Jiadai, Sun, Yifeng, Jiang, Jifeng, Xu, Zhao, Li, Jing, Xu, Tianhong, Liu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372013/ https://www.ncbi.nlm.nih.gov/pubmed/32760394 http://dx.doi.org/10.3389/fimmu.2020.01292 |
Ejemplares similares
-
Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy
por: Li, Xiaoyu, et al.
Publicado: (2019) -
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
por: Balduit, Andrea, et al.
Publicado: (2023) -
gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma
por: Peerschke, Ellinor, et al.
Publicado: (2020) -
Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR
por: Pednekar, Lina, et al.
Publicado: (2016) -
Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis
por: Kim, Beom-Chan, et al.
Publicado: (2016)